Abstract:Current studies have shown that long non-coding RNAs (lncRNAs) play a crucial role in a variety of fundamental biological processes related to complex human diseases. The prediction of latent disease-lncRNA associations can help to understand the pathogenesis of complex human diseases at the level of lncRNA, which also contributes to the detection of disease biomarkers, and the diagnosis, treatment, prognosis and prevention of disease. Nevertheless, it is still a challenging and urgent task to accurately identify latent disease-lncRNA association. Discovering latent links on the basis of biological experiments is time-consuming and wasteful, necessitating the development of computational prediction models. In this study, a computational prediction model has been remodeled as a matrix completion framework of the recommendation system by completing the unknown items in the rating matrix. A novel method named faster randomized matrix completion for latent disease-lncRNA association prediction (FRMCLDA) has been proposed by virtue of improved randomized partial SVD (rSVD-BKI) on a heterogeneous bilayer network. First, the correlated data source and experimentally validated information of diseases and lncRNAs are integrated to construct a heterogeneous bilayer network. Next, the integrated heterogeneous bilayer network can be formalized as a comprehensive adjacency matrix which includes lncRNA similarity matrix, disease similarity matrix, and disease-lncRNA association matrix where the uncertain disease-lncRNA associations are referred to as blank items. Then, a matrix approximate to the original adjacency matrix has been designed with predicted scores to retrieve the blank items. The construction of the approximate matrix could be equivalently resolved by the nuclear norm minimization. Finally, a faster singular value thresholding algorithm with a randomized partial SVD combing a new sub-space reuse technique has been utilized to complete the adjacency matrix. The results of leave-one-out cross-validation (LOOCV) experiments and 5-fold cross-validation (5-fold CV) experiments on three different benchmark databases have confirmed the availability and adaptability of FRMCLDA in inferring latent relationships of disease-lncRNA pairs, and in inferring lncRNAs correlated with novel diseases without any prior interaction information. Additionally, case studies have shown that FRMCLDA is able to effectively predict latent lncRNAs correlated with three widespread malignancies: prostate cancer, colon cancer, and gastric cancer.

Robust Inductive Matrix Completion Strategy to Explore Associations Between LincRNAs and Human Disease Phenotypes

Neural inductive matrix completion with graph convolutional networks for miRNA-disease association prediction

LncRNA-Disease Association Prediction Based on Graph Neural Networks and Inductive Matrix Completion

Improved Inductive Matrix Completion Method for Predicting MicroRNA-Disease Associations

Prediction of lncRNA–disease associations based on inductive matrix completion

Predicting miRNA-disease association based on inductive matrix completion.

Improved Prediction of miRNA-Disease Associations Based on Matrix Completion with Network Regularization

SNFIMCMDA: Similarity Network Fusion and Inductive Matrix Completion for miRNA–Disease Association Prediction

NFMCLDA: Predicting miRNA-based lncRNA-disease associations by network fusion and matrix completion

Inferring Latent Disease-lncRNA Associations by Faster Matrix Completion on a Heterogeneous Network

Predicting lincRNA-Disease Association in Heterogeneous Networks Using Co-regularized Non-negative Matrix Factorization

Dual Laplacian regularized matrix completion for microRNA-disease associations prediction

Prediction of circRNA-disease associations based on inductive matrix completion

Prior Knowledge Guided Gene-Disease Associations Prediction: An Enhanced Inductive Matrix Completion Approach

Inferring LncRNA-disease associations based on graph autoencoder matrix completion

Matrix Reconstruction with Reliable Neighbors for Predicting Potential MiRNA-disease Associations

LncRNA Expression Profile-Based Matrix Factorization for Predicting lncRNA- Disease Association

Identifying lncRNA–disease association based on GAT multiple-operator aggregation and inductive matrix completion

SCCPMD: Probability matrix decomposition method subject to corrected similarity constraints for inferring long non-coding RNA-disease associations

Identification of Disease-Associated MicroRNAs Via Locality-Constrained Linear Coding-Based Ensemble Learning

A machine learning framework that integrates multi-omics data predicts cancer-related LncRNAs